Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Abu Eid, S. | - |
| dc.contributor.author | Adams, M. | - |
| dc.contributor.author | Scherer, T. | - |
| dc.contributor.author | Torres-Gómez, H. | - |
| dc.contributor.author | Hackl, M.T. | - |
| dc.contributor.author | Riedl, R. | - |
| dc.contributor.author | Luger, A. | - |
| dc.contributor.author | Fürnsinn, C. | - |
| dc.date.accessioned | 2024-03-01T08:24:43Z | - |
| dc.date.available | 2024-03-01T08:24:43Z | - |
| dc.date.issued | 2016-09 | - |
| dc.identifier.issn | 0012-186X | de_CH |
| dc.identifier.issn | 1432-0428 | de_CH |
| dc.identifier.uri | https://digitalcollection.zhaw.ch/handle/11475/30073 | - |
| dc.description.abstract | Emodin is found in herbal remedies used in Traditional Chinese Medicine. Alongside its undisputed laxative action, emodin has been reported to lower blood glucose in hyperglycaemic rodents. Although purely experimental, these results are heralded in non-scientific (online-) sources to promote sales of emodin-containing herbal products as a natural cure for diabetes. While emodin-induced glucose lowering has been attributed to a surprising multitude of molecular mechanisms (activation of PPARγ, inhibition of 11β-HSD, activation of AMPK, etc.), little effort has been made to sort out, whether emodin merely acts via loss of appetite and body weight. | de_CH |
| dc.language.iso | en | de_CH |
| dc.publisher | Springer | de_CH |
| dc.relation.ispartof | Diabetologia | de_CH |
| dc.rights | Licence according to publishing contract | de_CH |
| dc.subject.ddc | 615: Pharmakologie und Therapeutik | de_CH |
| dc.subject.ddc | 616: Innere Medizin und Krankheiten | de_CH |
| dc.title | Emodin, a compound with acclaimed antidiabetic potential, deteriorates glucose tolerance in obese mice | de_CH |
| dc.type | Konferenz: Sonstiges | de_CH |
| dcterms.type | Text | de_CH |
| zhaw.departement | Life Sciences und Facility Management | de_CH |
| zhaw.organisationalunit | Institut für Chemie und Biotechnologie (ICBT) | de_CH |
| dc.identifier.doi | 10.1007/s00125-016-4046-9 | de_CH |
| zhaw.conference.details | 52nd EASD Annual Meeting, Munich, Germany, 12–16 September 2016 | de_CH |
| zhaw.funding.eu | No | de_CH |
| zhaw.issue | Suppl 1 | de_CH |
| zhaw.originated.zhaw | Yes | de_CH |
| zhaw.pages.start | S343 | de_CH |
| zhaw.publication.status | publishedVersion | de_CH |
| zhaw.volume | 59 | de_CH |
| zhaw.publication.review | Peer review (Abstract) | de_CH |
| zhaw.title.proceedings | Abstracts of 52nd EASD Annual Meeting | de_CH |
| zhaw.webfeed | CC Drug Discovery | de_CH |
| zhaw.webfeed | Organische Chemie | de_CH |
| zhaw.author.additional | No | de_CH |
| zhaw.display.portrait | Yes | de_CH |
| Appears in collections: | Publikationen Life Sciences und Facility Management | |
Files in This Item:
There are no files associated with this item.
Show simple item record
Abu Eid, S., Adams, M., Scherer, T., Torres-Gómez, H., Hackl, M. T., Riedl, R., Luger, A., & Fürnsinn, C. (2016). Emodin, a compound with acclaimed antidiabetic potential, deteriorates glucose tolerance in obese mice [Conference presentation]. Diabetologia, 59(Suppl 1), S343. https://doi.org/10.1007/s00125-016-4046-9
Abu Eid, S. et al. (2016) ‘Emodin, a compound with acclaimed antidiabetic potential, deteriorates glucose tolerance in obese mice’, in Diabetologia. Springer, p. S343. Available at: https://doi.org/10.1007/s00125-016-4046-9.
S. Abu Eid et al., “Emodin, a compound with acclaimed antidiabetic potential, deteriorates glucose tolerance in obese mice,” in Diabetologia, Sep. 2016, vol. 59, no. Suppl 1, p. S343. doi: 10.1007/s00125-016-4046-9.
ABU EID, S., M. ADAMS, T. SCHERER, H. TORRES-GÓMEZ, M.T. HACKL, R. RIEDL, A. LUGER und C. FÜRNSINN, 2016. Emodin, a compound with acclaimed antidiabetic potential, deteriorates glucose tolerance in obese mice. In: Diabetologia. Conference presentation. Springer. September 2016. S. S343
Abu Eid, S., M. Adams, T. Scherer, H. Torres-Gómez, M.T. Hackl, R. Riedl, A. Luger, and C. Fürnsinn. 2016. “Emodin, a Compound with Acclaimed Antidiabetic Potential, Deteriorates Glucose Tolerance in Obese Mice.” Conference presentation. In Diabetologia, 59:S343. Springer. https://doi.org/10.1007/s00125-016-4046-9.
Abu Eid, S., et al. “Emodin, a Compound with Acclaimed Antidiabetic Potential, Deteriorates Glucose Tolerance in Obese Mice.” Diabetologia, vol. 59, no. Suppl 1, Springer, 2016, p. S343, https://doi.org/10.1007/s00125-016-4046-9.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.